To study the efficacy of Chaturbeej churna in Pushpaghni Jataharini with special reference to polycystic ovarian syndrome
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2023/07/055605
- Lead Sponsor
- Swati Suresh Ambekar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Diagnosed Cases of PCOS(by Rotterdam criteria)-any2/3
a.Hyperandrogenism(clinical or biochemical)
b.oligomenorrhea(menstrual cycle >35 days)/Secondary amenorrhea
c. USG findings-PCO feature on USG i.e. peripherally arranged antral follicle count >12 with thickened stroma in ovaries/Ovarian volume >10cm3 in unilateral/bilateral ovaries.
a.Patient <16years and >45years
b.Patient showing symptoms other than PCOS
c.Patient having any other disease-causing oligomenorrhea and anovulation excluding PCOS
d.Patients suffering from- adrenal hyperplasia, severe insulin resistance,androgen secreting tumor, thyroid abnormalities, cardiac disease, Cushing syndrome, hyperprolactinemia
e. Pregnant patients
f.Patients with any organic lesions of reproductive tract like TB,CA,cogenital anomalies,
any other pelvic pathologies like fibroids
g.A current or previous use (within 3 months) of OCpills,Glucocorticoids,Antiandrogens,Antidiabetic,Antiobesity drugs or any hormonal therepy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the efficacy of Chaurbeej churna in the management of Polycystic ovarian syndromeTimepoint: At 3 months
- Secondary Outcome Measures
Name Time Method a.To study the efficacy of Chaturbeej churna in Pushpaghni Jataharini. <br/ ><br>b.To study Pushpaghni Jataharini according to Ayurveda in detail. <br/ ><br>c.To study PCOS according to modern science in detail. <br/ ><br>c.To study effectiveness of Chaturbeej Churna on menstrual cycle abnormalities,insulin resistance,hirsutism,BMI etc in PCOSTimepoint: At Baseline, At 1month,At 2 month